251 related articles for article (PubMed ID: 30205878)
1. Developing precision medicine using scarless genome editing of human pluripotent stem cells.
Steyer B; Cory E; Saha K
Drug Discov Today Technol; 2018 Aug; 28():3-12. PubMed ID: 30205878
[TBL] [Abstract][Full Text] [Related]
2. Efficient scarless genome editing in human pluripotent stem cells.
Ikeda K; Uchida N; Nishimura T; White J; Martin RM; Nakauchi H; Sebastiano V; Weinberg KI; Porteus MH
Nat Methods; 2018 Dec; 15(12):1045-1047. PubMed ID: 30504872
[TBL] [Abstract][Full Text] [Related]
3. Safe scarless cassette-free selection of genome-edited human pluripotent stem cells using temporary drug resistance.
Kim KT; Park JC; Jang HK; Lee H; Park S; Kim J; Kwon OS; Go YH; Jin Y; Kim W; Lee J; Bae S; Cha HJ
Biomaterials; 2020 Dec; 262():120295. PubMed ID: 32916603
[TBL] [Abstract][Full Text] [Related]
4. Use of genome editing tools in human stem cell-based disease modeling and precision medicine.
Wei YD; Li S; Liu GG; Zhang YX; Ding QR
Yi Chuan; 2015 Oct; 37(10):983-91. PubMed ID: 26496750
[TBL] [Abstract][Full Text] [Related]
5. Precise and efficient scarless genome editing in stem cells using CORRECT.
Kwart D; Paquet D; Teo S; Tessier-Lavigne M
Nat Protoc; 2017 Feb; 12(2):329-354. PubMed ID: 28102837
[TBL] [Abstract][Full Text] [Related]
6. Genome editing in pluripotent stem cells: research and therapeutic applications.
Deleidi M; Yu C
Biochem Biophys Res Commun; 2016 May; 473(3):665-74. PubMed ID: 26930470
[TBL] [Abstract][Full Text] [Related]
7. Scarless Genome Editing of Human Pluripotent Stem Cells via Transient Puromycin Selection.
Steyer B; Bu Q; Cory E; Jiang K; Duong S; Sinha D; Steltzer S; Gamm D; Chang Q; Saha K
Stem Cell Reports; 2018 Feb; 10(2):642-654. PubMed ID: 29307579
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9 genome editing in human pluripotent stem cells: Harnessing human genetics in a dish.
González F
Dev Dyn; 2016 Jul; 245(7):788-806. PubMed ID: 27145095
[TBL] [Abstract][Full Text] [Related]
9. Genome engineering of stem cell organoids for disease modeling.
Sun Y; Ding Q
Protein Cell; 2017 May; 8(5):315-327. PubMed ID: 28102490
[TBL] [Abstract][Full Text] [Related]
10. Protocol for scarless genome editing of human pluripotent stem cell based on orthogonal selective reporters.
Zhao Y; Pan Z; Hong Z; Sun M; Hong Y; Peng X; Li X; Wang X; Wang K
STAR Protoc; 2024 Jun; 5(2):103084. PubMed ID: 38787727
[TBL] [Abstract][Full Text] [Related]
11. Stem cell contributions to neurological disease modeling and personalized medicine.
Liang N; Trujillo CA; Negraes PD; Muotri AR; Lameu C; Ulrich H
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt A):54-62. PubMed ID: 28576415
[TBL] [Abstract][Full Text] [Related]
12. A Scaled Framework for CRISPR Editing of Human Pluripotent Stem Cells to Study Psychiatric Disease.
Hazelbaker DZ; Beccard A; Bara AM; Dabkowski N; Messana A; Mazzucato P; Lam D; Manning D; Eggan K; Barrett LE
Stem Cell Reports; 2017 Oct; 9(4):1315-1327. PubMed ID: 29020615
[TBL] [Abstract][Full Text] [Related]
13. Improving single-cell cloning workflow for gene editing in human pluripotent stem cells.
Chen YH; Pruett-Miller SM
Stem Cell Res; 2018 Aug; 31():186-192. PubMed ID: 30099335
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-Cas9: A cornerstone for the evolution of precision medicine.
Razzouk S
Ann Hum Genet; 2018 Nov; 82(6):331-357. PubMed ID: 30014471
[TBL] [Abstract][Full Text] [Related]
15. Gene editing with 'pencil' rather than 'scissors' in human pluripotent stem cells.
Park JC; Park MJ; Lee SY; Kim D; Kim KT; Jang HK; Cha HJ
Stem Cell Res Ther; 2023 Jun; 14(1):164. PubMed ID: 37340491
[TBL] [Abstract][Full Text] [Related]
16. Small molecules promote CRISPR-Cpf1-mediated genome editing in human pluripotent stem cells.
Ma X; Chen X; Jin Y; Ge W; Wang W; Kong L; Ji J; Guo X; Huang J; Feng XH; Fu J; Zhu S
Nat Commun; 2018 Apr; 9(1):1303. PubMed ID: 29610531
[TBL] [Abstract][Full Text] [Related]
17. Design and Validation of CRISPR/Cas9 Systems for Targeted Gene Modification in Induced Pluripotent Stem Cells.
Lee CM; Zhu H; Davis TH; Deshmukh H; Bao G
Methods Mol Biol; 2017; 1498():3-21. PubMed ID: 27709565
[TBL] [Abstract][Full Text] [Related]
18. Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation.
Blair JD; Bateup HS; Hockemeyer DF
J Vis Exp; 2016 Feb; (108):e53583. PubMed ID: 26863600
[TBL] [Abstract][Full Text] [Related]
19. Assembly of CRISPR ribonucleoproteins with biotinylated oligonucleotides via an RNA aptamer for precise gene editing.
Carlson-Stevermer J; Abdeen AA; Kohlenberg L; Goedland M; Molugu K; Lou M; Saha K
Nat Commun; 2017 Nov; 8(1):1711. PubMed ID: 29167458
[TBL] [Abstract][Full Text] [Related]
20. Genome Editing in Human Pluripotent Stem Cells.
Carlson-Stevermer J; Saha K
Methods Mol Biol; 2017; 1590():165-174. PubMed ID: 28353269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
